296 related articles for article (PubMed ID: 25714017)
21. Gene and cell therapy for pancreatic cancer.
Singh HM; Ungerechts G; Tsimberidou AM
Expert Opin Biol Ther; 2015 Apr; 15(4):505-16. PubMed ID: 25582170
[TBL] [Abstract][Full Text] [Related]
22. Molecular targeted therapy for pancreatic adenocarcinoma: A review of completed and ongoing late phase clinical trials.
Mosquera C; Maglic D; Zervos EE
Cancer Genet; 2016 Dec; 209(12):567-581. PubMed ID: 27613577
[TBL] [Abstract][Full Text] [Related]
23. Infiltrating immune cells and gene mutations in pancreatic ductal adenocarcinoma.
Wang WQ; Liu L; Xu HX; Wu CT; Xiang JF; Xu J; Liu C; Long J; Ni QX; Yu XJ
Br J Surg; 2016 Aug; 103(9):1189-99. PubMed ID: 27256393
[TBL] [Abstract][Full Text] [Related]
24. Screening for pancreatic cancer in familial high-risk individuals: A systematic review.
Lu C; Xu CF; Wan XY; Zhu HT; Yu CH; Li YM
World J Gastroenterol; 2015 Jul; 21(28):8678-86. PubMed ID: 26229410
[TBL] [Abstract][Full Text] [Related]
25. Personalized therapy for pancreatic cancer: Do we need better targets, arrows, or both?
O'Hayer KM; Brody JR
Discov Med; 2016 Feb; 21(114):117-23. PubMed ID: 27011047
[TBL] [Abstract][Full Text] [Related]
26. Immunohistochemically detected expression of 3 major genes (CDKN2A/p16, TP53, and SMAD4/DPC4) strongly predicts survival in patients with resectable pancreatic cancer.
Oshima M; Okano K; Muraki S; Haba R; Maeba T; Suzuki Y; Yachida S
Ann Surg; 2013 Aug; 258(2):336-46. PubMed ID: 23470568
[TBL] [Abstract][Full Text] [Related]
27. Measurement of copy number of ACTN4 to optimize the therapeutic strategy for locally advanced pancreatic cancer.
Shoji H; Miura N; Ueno H; Honda K
Pancreatology; 2018 Sep; 18(6):624-629. PubMed ID: 29921500
[TBL] [Abstract][Full Text] [Related]
28. [A Novel Treatment Strategy for Pancreatic Cancer Based on Gene Profiles].
Hayashi H; Nishihara H
Gan To Kagaku Ryoho; 2016 Nov; 43(11):1326-1331. PubMed ID: 27899773
[TBL] [Abstract][Full Text] [Related]
29. The pancreatic cancer genome revisited.
Hayashi A; Hong J; Iacobuzio-Donahue CA
Nat Rev Gastroenterol Hepatol; 2021 Jul; 18(7):469-481. PubMed ID: 34089011
[TBL] [Abstract][Full Text] [Related]
30. Pancreatic cancer: the role of molecular markers in diagnosis and management.
Lowery MA; O'Reilly EM
Clin Adv Hematol Oncol; 2011 Dec; 9(12):900-8. PubMed ID: 22252658
[TBL] [Abstract][Full Text] [Related]
31. Molecular pathogenesis of pancreatic cancer.
Maitra A; Kern SE; Hruban RH
Best Pract Res Clin Gastroenterol; 2006 Apr; 20(2):211-26. PubMed ID: 16549325
[TBL] [Abstract][Full Text] [Related]
32. Gene overexpression in pancreatic adenocarcinoma: diagnostic and therapeutic implications.
Rodriguez JA; Li M; Yao Q; Chen C; Fisher WE
World J Surg; 2005 Mar; 29(3):297-305. PubMed ID: 15696394
[TBL] [Abstract][Full Text] [Related]
33. Meta-analysis of transcriptome data identifies a novel 5-gene pancreatic adenocarcinoma classifier.
Bhasin MK; Ndebele K; Bucur O; Yee EU; Otu HH; Plati J; Bullock A; Gu X; Castan E; Zhang P; Najarian R; Muraru MS; Miksad R; Khosravi-Far R; Libermann TA
Oncotarget; 2016 Apr; 7(17):23263-81. PubMed ID: 26993610
[TBL] [Abstract][Full Text] [Related]
34. Epigenetic markers for chemosensitivity and chemoresistance in pancreatic cancer--a review.
Dhayat S; Mardin WA; Mees ST; Haier J
Int J Cancer; 2011 Sep; 129(5):1031-41. PubMed ID: 21413017
[TBL] [Abstract][Full Text] [Related]
35. Therapeutic Implications of Molecular Subtyping for Pancreatic Cancer.
Pishvaian MJ; Brody JR
Oncology (Williston Park); 2017 Mar; 31(3):159-66, 168. PubMed ID: 28299752
[TBL] [Abstract][Full Text] [Related]
36. Gene therapy developments for pancreatic cancer.
Bhattacharyya M; Lemoine NR
Best Pract Res Clin Gastroenterol; 2006 Apr; 20(2):285-98. PubMed ID: 16549328
[TBL] [Abstract][Full Text] [Related]
37. Current and future biomarkers for pancreatic adenocarcinoma.
Loosen SH; Neumann UP; Trautwein C; Roderburg C; Luedde T
Tumour Biol; 2017 Jun; 39(6):1010428317692231. PubMed ID: 28618958
[TBL] [Abstract][Full Text] [Related]
38. Biomarkers for personalized medicine in GI cancers.
Zhang SY; Zhang SQ; Nagaraju GP; El-Rayes BF
Mol Aspects Med; 2015 Nov; 45():14-27. PubMed ID: 26054566
[TBL] [Abstract][Full Text] [Related]
39. Molecular genetics of pancreatic intraepithelial neoplasia.
Feldmann G; Beaty R; Hruban RH; Maitra A
J Hepatobiliary Pancreat Surg; 2007; 14(3):224-32. PubMed ID: 17520196
[TBL] [Abstract][Full Text] [Related]
40. Molecular pathogenesis of pancreatic adenocarcinoma: potential clinical implications.
Talar-Wojnarowska R; Malecka-Panas E
Med Sci Monit; 2006 Sep; 12(9):RA186-93. PubMed ID: 16940943
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]